Study To Evaluate The Effects Of Gabitril™ In Patients With Social Anxiety Disorder
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Philip T Ninan, MD
Emory University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Emory University School of Medicine
Atlanta, Georgia, United States
- Hillside Hospital of the North Shore-Long Island Jewish Health System
Long Island City, New York, United States
- Columbia/new York State Psychiatric Institute
New York, New York, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2002
- Primary completion
- —
- Completion
- 30 Nov 2003
- Last update posted
- 11 Nov 2013
- Registered enrollment
- 50
- Registry id
- NCT00208741
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.